# Semaglutide Therapy for Alcohol Reduction - Tulsa

> **NCT05891587** · PHASE2 · COMPLETED · sponsor: **Oklahoma State University Center for Health Sciences** · enrollment: 80 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Semaglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05891587
- **Lead sponsor:** Oklahoma State University Center for Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-07
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-10-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05891587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05891587, "Semaglutide Therapy for Alcohol Reduction - Tulsa". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05891587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*